Prognostic value of S-100 immunostaining in tumour cells of non-small cell lung cancer

References

• Ambartsumian N, Gridorian M, Lukanidin E. 2005. Genetically modified mouse models to study the role of metastasis-promoting S100A4 (mts1) protein in metastatic mammary cancer. Journal of Dairy Research 72: 27–33.
   PubMed Web of Science ®Google Scholar
• Ambe K, Mori M, Enjoji M. S-100 protein positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis. Cancer 1989; 63: 496–503
   PubMed Web of Science ®Google Scholar
• Camby I, Nagy N, Lopes MB, Schafer BzW, Maurage CA, Ruchoux MM, Murmann P, Pochet R, Heizmann CW, Brotchi J, et al. Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential expression of S 100 proteins. Brain Pathology 1999; 9: 1–19
   PubMed Web of Science ®Google Scholar
• Castets F, Griffin WS, Marks A, Van Eldik LJ. Transcriptional regulation of the human S 100 beta gene. Molecular Brain Research 1997; 46: 208–216
   PubMedGoogle Scholar
• Cho Y-G, Kim Ch-J, Nam S-W, Yoon Sh-H, Lee J-Y, Park W-S. 2005. Overexpression of S100A4 is closely associated with progression of colorectal cancer. World Journal of Gastroenterology 21: 4852–4856.
   Google Scholar
• Coppola D, Fu L, Nicosia SV, Kounelis S, Jones M. Prognostic significance of p53, bcl-2, vimentin, and S100 protein positive Langerhans cells in endometrial carcinoma. Human Pathology 1998; 29: 455–462
   PubMed Web of Science ®Google Scholar
• Fano G, Biocca S, Fulle S, Mariggio MA, Belia S, Calissano P. The S-100: a protein family in search of a function. Progress in Neurobiology 1995; 46: 71–82
   PubMed Web of Science ®Google Scholar
• Feng G, Xu X-Ch, Youssef EM, Lotan R. Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis. Cancer Research 2001; 61: 7999–8004
   PubMed Web of Science ®Google Scholar
• Furukawa T, Watanabe S, Kodama T, Sato Y, Shimosato Y, Suemasu K. T-zone histiocytes in adenocarcinoma of the lung in relation to postoperative prognosis. Cancer 1985; 56: 2651–2656
   PubMed Web of Science ®Google Scholar
• Heighway J, Knapp T, Boyce L, Brennand S, Field JK, Betticher DC, Ratschiller D, Gugger M, Donovan M, Lasek A, Rickert P. Expression profiling of primary non-small lung cancer for target identification. Oncogene 2002; 21: 7749–7763
   PubMed Web of Science ®Google Scholar
• Hermani A, Hess J, De Servi B, Medunjanin S, Grobholz R, Trojan L, Angel P, Mayer D. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer. Clinical Cancer Research 2005; 11: 5146–5152
   PubMed Web of Science ®Google Scholar
• Honig A, Schaller N, Dietl J, Backe J, Kammerer U. S100 as an immunohistochemically-detected marker with prognostic significance in endometrial carcinoma. Anticancer Research 2005; 25: 1747–1753
   PubMed Web of Science ®Google Scholar
• Ikeguchi M, Ikeda M, Tatebe S, Maeta M, Kaibara N. Clinical significance of dendritic cells infiltration in esophageal squamous carcinoma. Oncology Report 1998; 5: 1185–1189
   PubMed Web of Science ®Google Scholar
• Ioachim HL, Dorsett BH, Paluch B. The immune response at the tumor site in lung carcinoma. Cancer 1976; 38: 2296–2309
   PubMed Web of Science ®Google Scholar
• Jassem E, Gozdz S, Badzio A, Kobierska G, Skokowski J, Damps I, Urbaniak A, Jassem J. Prognostic value of p53 expression in non-small cell lung cancer cells]. Pneumonologia i Alergologia Polska 2000; 68: 327–335
   PubMedGoogle Scholar
• Johnson SK, Kerr KM, Chapman AD, Kennedy MM, King G, Cockburn JS, Jeffrey RR. Immune cell infiltrates and prognosis in primary carcinoma of the lung. Lung Cancer 2000; 27: 27–35
   PubMed Web of Science ®Google Scholar
• Kimura K, Endo Y, Yonemura Y, Heizmann CW, Schafer BW, Watanabe Y, Sasaki T. Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer. International Journal of Cancer 2000; 16: 1125–1231
   Google Scholar
• Kligman D, Hilt DC. The S100 protein family. Trends in Biochemistry Sciences 1988; 13: 437–443
   PubMed Web of Science ®Google Scholar
• Lauriola L, Michetti F, Maggiano N, Galli J, Cadoni G, Schafer BW, Heizmann CW, Ranelletti FO. Prognostic significance of the Ca (2 + ) binding protein S100A2 in laryngeal squamous-cell carcinoma. International Journal of Cancer 2000; 89: 345–349
   PubMed Web of Science ®Google Scholar
• Lesniak W, Swart GWM, Bloemers HPJ, Kuznicki J. Regulation of cell specific expression of calcyclin (S100A6) in nerve cells and other tissues. Acta Neurobiologica Experimentialis 2000; 60: 569–575
   PubMed Web of Science ®Google Scholar
• Matsushima S, Mori M, Adachi Y, Matsukuma A, Sugimachi K. S100-protein positive human breast carcinomas. An Immunohistochemical study. Journal of Surgical Oncology 1994; 55: 108–113
   PubMed Web of Science ®Google Scholar
• Mueller A, Bachi T, Hochli M, Schafer BW, Heizmann CW. Subcellular distribution of S100 proteins in tumor cells and their relocation in response to calcium activation. Histochemistry and Cell Biology 1999; 111: 453–459
   PubMed Web of Science ®Google Scholar
• Nakajima T, Kodama T, Tsumuraya M, Shimosato Y, Kameya T. S-100 protein-positive Langerhans cells in various human lung cancers, especially in peripheral adenocarcinoma. Virchows Archiv 1985; 407: 177–189
   Web of Science ®Google Scholar
• Nakamura H, Ishigrud K, Mori T. Different immune functions of peripheral blood regional lymph node, and tumor infiltrating lymphocytes in lung cancer patients. Cancer 1988; 62: 2489–2497
   PubMed Web of Science ®Google Scholar
• Nakano T, Oka K, Hanba K, Morita S. Intratumoral administration of sizofiran activates Langerhans cell and T-cell infiltration in cervical cancer. Clinical Immunology and Immunopathology 1996; 79: 79–86
   PubMedGoogle Scholar
• Schafer BW, Heizmann CW. The S100 family of EF-hand calcium binding proteins: functions and pathology. Trends in Biochemical Sciences 1996; 21: 134–140
   PubMed Web of Science ®Google Scholar
• Schafer BW, Wicki R, Engelkamp D, Mattei MG, Heizmann CW. Isolation of YAC clone covering a cluster of nine S100 genes on human chromosome 1q21. Rationale for a new nomenclature of the S100 calcium binding protein family. Genomics 1995; 25: 638–643
   PubMed Web of Science ®Google Scholar
• Schroder S, Schwarz W, Rehpenning W, Loning T, Bocker W. Dendritic Langerhans cells and prognosis in patients with papillary thyroid carcinomas. American Journal in Clinical Pathology 1988; 89: 295–300
   PubMed Web of Science ®Google Scholar
• Wicki R, Franz C, Scholl FA, Heizmann CW, Schafer BW. Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site-specific hypermethylation. Cell Calcium 1997; 22: 243–254
   PubMed Web of Science ®Google Scholar
• Zeid NA, Muller HK. S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival. Pathology 1993; 25: 338–343
   PubMed Web of Science ®Google Scholar
• Zimmer DB, Cornwall EH, Landar A, Song W. The S100 protein family: history, function, and expression. Brain Research Bulletin 1995; 37: 417–429
   PubMed Web of Science ®Google Scholar
• Zoltowska A, Moszkowska G, Zamorska B, Roszkiewicz A. Immunohistochemical study in breast carcinoma, S100-protein positive cells and neuroednocrine differentiation. Archivum Immunologiae et Therapiae Experimentalis 1996; 44: 271–277
   PubMedGoogle Scholar